Journal articles on the topic 'SCD89'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'SCD89.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Berthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza, et al. "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors." Journal of Experimental Medicine 209, no. 4 (March 26, 2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Wu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang, and Ruitong Gao. "Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History." Disease Markers 2020 (January 16, 2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
van Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha, and Cees van Kooten. "Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89." Journal of Immunology 163, no. 11 (December 1, 1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Di Leo, Vincenzo, Patrick J. Gleeson, Fabio Sallustio, Carine Bounaix, Jennifer Da Silva, Gesualdo Loreto, Sanae Ben Mkaddem, and Renato C. Monteiro. "Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model." Journal of Personalized Medicine 11, no. 4 (April 16, 2021): 309. http://dx.doi.org/10.3390/jpm11040309.
Esteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey, and Eva Mª Martínez Cáceres. "Immunological Pattern in IgA Nephropathy." International Journal of Molecular Sciences 21, no. 4 (February 18, 2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Zych, Michał, Aleksander Roszczyk, Filip Dąbrowski, Monika Kniotek, and Radosław Zagożdżon. "Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss—A Preliminary Study." International Journal of Molecular Sciences 25, no. 1 (December 29, 2023): 499. http://dx.doi.org/10.3390/ijms25010499.
Liu, Chao, Xiaohui Li, Aijie Li, Wenxue Zou, Rui Huang, Xiaoyu Hu, Jinming Yu, Xiaoling Zhang, and Jinbo Yue. "Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer." Journal of Immunology Research 2022 (April 4, 2022): 1–8. http://dx.doi.org/10.1155/2022/9621466.
Odagiri, Naoshi, Hoang Hai, Le Thi Thanh Thuy, Minh Phuong Dong, Maito Suoh, Kohei Kotani, Atsushi Hagihara, et al. "Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization." Cancers 12, no. 8 (July 24, 2020): 2045. http://dx.doi.org/10.3390/cancers12082045.
KAKOULIDOU, M., X. WANG, X. ZHAO, R. PIRSKANEN, and A. LEFVERT. "Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis." Journal of Neuroimmunology 185, no. 1-2 (April 2007): 150–61. http://dx.doi.org/10.1016/j.jneuroim.2007.01.007.
Lin, Wei. "sCD83 alleviates experimental autoimmune uveitis through disrupting the regulation of Rab1a/LRRK2 on F-actin rearrangements." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 116.2. http://dx.doi.org/10.4049/jimmunol.202.supp.116.2.
Zelek, Wioleta M., Lewis M. Watkins, Owain W. Howell, Rhian Evans, Sam Loveless, Neil P. Robertson, Marijke Beenes, Loek Willems, Ricardo Brandwijk, and B. Paul Morgan. "Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59." Multiple Sclerosis Journal 25, no. 4 (February 9, 2018): 523–31. http://dx.doi.org/10.1177/1352458518758927.
Kang, Seon Mee, Jun Choul Lee, and Bon Jeong Ku. "Changes in Soluble Serum CD81 Concentration during an Oral Glucose Tolerance Test in Patients with Diabetes Mellitus and Individuals with Normal Glucose Tolerance." Diagnostics 13, no. 23 (November 21, 2023): 3500. http://dx.doi.org/10.3390/diagnostics13233500.
Liu, Shen, Chaoqun Huang, Dawei Li, Weihua Ren, Haoxing Zhang, Meiyan Qi, Xin Li, and Long Yu. "Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9." Acta Biochimica Polonica 54, no. 1 (February 20, 2007): 213–18. http://dx.doi.org/10.18388/abp.2007_3289.
Einenkel, Rebekka, Katrin Regina Helene Packhäuser, Jens Ehrhardt, Anne Tüngler, Marek Zygmunt, and Damián Oscar Muzzio. "CD83 is locally regulated and differentially expressed in disturbed murine pregnancy." Reproduction 158, no. 4 (October 2019): 323–33. http://dx.doi.org/10.1530/rep-19-0171.
Linker-Israeli, M., S. Hyun, T. Ozeri-Chen, D. J. Wallace, K. Banks, and J. R. Klinenberg. "Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus." Journal of Immunology 152, no. 6 (March 15, 1994): 3158–67. http://dx.doi.org/10.4049/jimmunol.152.6.3158.
Gong, Xingyu, Tianyi Ma, Qiaoya Zhang, Yanhong Wang, Chengchuang Song, Min Lai, Chunlei Zhang, Xingtang Fang, and Xi Chen. "Porcine Reproductive and Respiratory Syndrome Virus Modulates the Switch of Macrophage Polarization from M1 to M2 by Upregulating MoDC-Released sCD83." Viruses 15, no. 3 (March 17, 2023): 773. http://dx.doi.org/10.3390/v15030773.
Ishibashi, Mariko, Ryosuke Kinoshita, Koiti Inokuchi, Hiroshi Handa, Makoto Sasaki, Norio Komatsu, Yoichi Imai, et al. "Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression." Blood 134, Supplement_1 (November 13, 2019): 4361. http://dx.doi.org/10.1182/blood-2019-124635.
Muñiz, Carmen, Lourdes Martín-Martín, Antonio López, Blanca Sánchez-González, Antonio Salar, Julia Almeida, Juan-Manuel Sancho, et al. "Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome." Blood 123, no. 12 (March 20, 2014): 1864–69. http://dx.doi.org/10.1182/blood-2013-11-537993.
Ho, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers, and W. Hunstein. "Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia." Blood 75, no. 5 (March 1, 1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.bloodjournal7551119.
Ho, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers, and W. Hunstein. "Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia." Blood 75, no. 5 (March 1, 1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.1119.
Lundell, Anna-Carin, Kerstin Andersson, Elisabet Josefsson, Alexander Steinkasserer, and Anna Rudin. "Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation." Infection and Immunity 75, no. 8 (May 25, 2007): 4097–104. http://dx.doi.org/10.1128/iai.01744-06.
Kogure, T., T. Itoh, Y. Shimada, T. Shintani, H. Ochiai, and K. Terasawa. "Detection of serum soluble markers of immune activation in rheumatoid arthritis." Mediators of Inflammation 5, no. 4 (1996): 262–65. http://dx.doi.org/10.1155/s0962935196000373.
Olszewski, Jurek, Wiesław Chudzik, Kazimierz Wiśniewski, Jarosław Miłonski, and Robert Matyja. "An Assessment of Concentrations of Soluble CD4 and CD8 Receptors in Serum before and after Surgical Treatment in Patients with Chronic Maxillary Sinusitis." American Journal of Rhinology 17, no. 3 (May 2003): 123–26. http://dx.doi.org/10.1177/194589240301700301.
Peckert-Maier, Katrin, Dmytro Royzman, Pia Langguth, Anita Marosan, Astrid Strack, Atefeh Sadeghi Shermeh, Alexander Steinkasserer, Elisabeth Zinser, and Andreas B. Wild. "Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation." International Journal of Molecular Sciences 23, no. 2 (January 10, 2022): 732. http://dx.doi.org/10.3390/ijms23020732.
Kubysheva, Nailya, Larisa Postnikova, Svetlana Soodaeva, Viкtor Novikov, Tatyana Eliseeva, Ildar Batyrshin, Timur Li, Igor Klimanov, and Alexander Chuchalin. "Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients." Disease Markers 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/8216723.
Yin, Xin-Ke, Chao Wang, Li-Li Feng, Shao-Mei Bai, Wei-Xing Feng, Neng-Tai Ouyang, Zhong-Hua Chu, Xin-Juan Fan, and Qi-Yuan Qin. "Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy." Cancers 14, no. 22 (November 14, 2022): 5573. http://dx.doi.org/10.3390/cancers14225573.
Moretti, Edgardo, Beatriz Basso, Liliana Cervetta, Ana Brigada, and Gustavo Barbieri. "Patterns of Cytokines and Soluble Cellular Receptors in the Sera of Children with Acute Chagas' Disease." Clinical and Vaccine Immunology 9, no. 6 (November 2002): 1324–27. http://dx.doi.org/10.1128/cdli.9.6.1324-1327.2002.
Jiang, Chun-Xuan. "THE PRIME PRINCIPLE IN CLUSTERS AND NANOSTRUCTURES." Algebras Groups and Geometries 39, no. 2 (December 1, 2023): 189–95. http://dx.doi.org/10.29083/agg.39.02.2023/sc189.
Ho, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck, and RE Corringham. "Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation." Blood 84, no. 10 (November 15, 1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.3550.
Ho, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck, and RE Corringham. "Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation." Blood 84, no. 10 (November 15, 1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.bloodjournal84103550.
Ho, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz, and W. Hunstein. "Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma." Blood 75, no. 1 (January 1, 1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.203.
Ho, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz, and W. Hunstein. "Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma." Blood 75, no. 1 (January 1, 1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.bloodjournal751203.
Putz, D., U. Barnas, A. Luger, G. Mayer, W. Woloszczuk, and H. Graf. "Biocompatibility of High-Flux Membranes." International Journal of Artificial Organs 15, no. 8 (August 1992): 456–60. http://dx.doi.org/10.1177/039139889201500802.
Hamed, Nahla, Nahla Farahat, Manal El Sorady, Dalia Nafee, and Sherine Barakat. "Clinical significance of sCD86 levels in patients with acute myelogenous leukemia." Alexandria Journal of Medicine 47, no. 1 (March 1, 2011): 25–30. http://dx.doi.org/10.1016/j.ajme.2011.04.002.
Nascimento, Catarina, Andreia Gameiro, Jorge Correia, João Ferreira, and Fernando Ferreira. "The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications." Cells 11, no. 16 (August 18, 2022): 2578. http://dx.doi.org/10.3390/cells11162578.
Kashchenko, Mikhail. "INTERPRETATION OF THE MECHANISM OF THE INFLUENCE OF π0- MESONS ON THE PROCESS OF ATTRACTION OF NUCLEI." Hadronic Journal 47, no. 1 (March 1, 2024): 89–94. http://dx.doi.org/10.29083/hj.47.01.2024/sc89.
Díaz García, Elena, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz Hernández, et al. "Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation." IBJ Plus 1, s5 (June 3, 2022): 1. http://dx.doi.org/10.24217/2531-0151.22v1s5.00001.
Barlan, Işil B., M. M. Başaran, M. Bakir, F. Tükenmez, and Nural Bekiroğlu. "Serum TNF-α, sCD8 and sIL-2R levels in childhood tuberculosis." Infection 23, no. 4 (July 1995): 237–39. http://dx.doi.org/10.1007/bf01781205.
Pujalte, J. M. "Présence pulmonaire de sCD87 au cours du syndrome de détresse respiratoire aiguë (SDRA)." Revue des Maladies Respiratoires 21, no. 6 (December 2004): 1212. http://dx.doi.org/10.1016/s0761-8425(04)71619-8.
Spathas, Nikolaos, Anna C. Goussia, Georgia-Angeliki Koliou, Helen Gogas, Flora Zagouri, Anna Batistatou, Antonia V. Charchanti, et al. "Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study." Cancers 14, no. 22 (November 16, 2022): 5635. http://dx.doi.org/10.3390/cancers14225635.
Ozkorucu, Duygu, Nuran Cetin, Nadide Melike Sav, and Bilal Yildiz. "Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome." International Urology and Nephrology 48, no. 7 (February 27, 2016): 1187–96. http://dx.doi.org/10.1007/s11255-016-1249-4.
Sanders, David E., Mark S. Stave, Leslie S. Perkins, and Andrew E. DePristo. "SCT89: a computer code for atomic and molecular scattering from clean and adsorbate covered surfaces." Computer Physics Communications 70, no. 3 (July 1992): 579–608. http://dx.doi.org/10.1016/0010-4655(92)90118-i.
De Rie, MA, IM Zonneveld, L. Witkamp, RA Van Lier, TA Out, and JD Bos. "Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1." Acta Dermato-Venereologica 76, no. 5 (September 1, 1996): 357–60. http://dx.doi.org/10.2340/0001555576357360.
Kuryliszyn-Moskal, A., K. Bemacka, and O. Bielecka. "Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis." Immunology Letters 56 (May 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)86296-7.
Kuryliszyn-Moskal, A. "Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis." Immunology Letters 56, no. 1-3 (May 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)88134-5.
Brasoveanu, L. I., E. Fonsatti, A. Visintin, M. Pavlovic, I. Cattarossi, F. Colizzi, A. Gasparollo, et al. "Melanoma cells constitutively release an anchor-positive soluble protectin (sCD59) that retains functional activities in complement-mediated cytotoxicity." Melanoma Research 7, Supplement 1 (June 1997): S10. http://dx.doi.org/10.1097/00008390-199706001-00034.
Kim, Han-Soo, Dimitrios Degiannis, Jana Raskova, and Karel Raska. "Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: Correlation with proliferative responses." Clinical Immunology and Immunopathology 60, no. 1 (July 1991): 27–39. http://dx.doi.org/10.1016/0090-1229(91)90109-n.
van der Merwe, P. Anton, Dale L. Bodian, Susan Daenke, Peter Linsley, and Simon J. Davis. "CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics." Journal of Experimental Medicine 185, no. 3 (February 3, 1997): 393–404. http://dx.doi.org/10.1084/jem.185.3.393.
Caruso, C., G. Candore, D. Cigna, S. Tripi, G. Di Gaetano, G. Migneco, G. Montalto, I. Ruggieri, and A. Notarbartolo. "Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis." Mediators of Inflammation 3, no. 3 (1994): 185–87. http://dx.doi.org/10.1155/s0962935194000256.
Martens, A., RAJ Janssen, DTh Sleijfer, AA Heijn, NH Mulder, TH The, and L. de Leij. "Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response." British Journal of Cancer 67, no. 5 (May 1993): 1118–21. http://dx.doi.org/10.1038/bjc.1993.205.